Structure

InChI Key PGLIUCLTXOYQMV-GHVWMZMZSA-N
Smile Cl.Cl.O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1
InChI
InChI=1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H27Cl3N2O3
Molecular Weight 461.82
AlogP 3.15
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 8.0
Polar Surface Area 53.01
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 27.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Histamine H1 receptor antagonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Rhinitis 3 D012220 ClinicalTrials
Cough 2 D003371 ClinicalTrials
Lecithin Cholesterol Acyltransferase Deficiency 1 D007863 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
21.06
Nervous system disorders
15.88
Psychiatric disorders
12.2
Respiratory, thoracic and mediastinal disorders
6.94
Injury, poisoning and procedural complications
6.64
Skin and subcutaneous tissue disorders
5.98
Gastrointestinal disorders
4.34
Immune system disorders
4.22
Cardiac disorders
3.81
Vascular disorders
3.77
Investigations
2.49

Cross References

Resources Reference
ChEMBL CHEMBL1201190
FDA SRS SOD6A38AGA
PubChem 9955977
SureChEMBL SCHEMBL144375